NCT02164084View on ClinicalTrials.gov

A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions
Acne Vulgaris
Interventions
DRUG

SB204

SB204 Gel with hydrogel

DRUG

Vehicle Gel

Vehicle Gel with hydrogel

Trial Locations (1)

53095

Spaulding Clinical Research, LLC, West Bend

All Listed Sponsors
lead

Novan, Inc.

INDUSTRY

NCT02164084 - A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris | Biotech Hunter | Biotech Hunter